We are delighted to announce our speakers line-up for the Innovation Forum 2016 conference. Follow us to keep up to date as we introduce our eminent speakers.
Dr Ann Connolly is Senior Director of New Ventures at Johnson & Johnson Innovation, London.
Her role involves seeking out the best science and technology available to deliver next generation therapies for serious diseases. Once identified, Ann works with J&J and the partner organisations to put together the right collaboration framework to transform those innovations into products.
Ann has extensive experience in the Pharmaceutical Industry; prior to joining J&J she was Senior Director of Business development with UCB Pharma where she was responsible for Business Development activities to support both the Immunology and CNS early phase portfolio. Ann has also spent 13 years in various drug development roles at GSK. During her time there she worked in preclinical development supporting the progression of multiple programmes in many therapeutic areas through the drug development process. She was also part of the GSK Neurology Centre of Excellence providing preclinical input for the early phase development portfolio. Ann is a scientist by training and holds a PhD in Biochemical Toxicology from the University of Surrey.